Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study

Background: Concomitant liver and lung transplant (ConLi-LTx) may be indicated for select pediatric patients with cystic fibrosis (CF). This study aims to analyze pre-transplant predictors and post-transplant outcomes of ConLi-LTx and lung transplant (LTx) only in pediatric patients with cystic fibr...

Full description

Saved in:
Bibliographic Details
Main Authors: Renita Wilson, BS, J. Asher Jenkins, MD, Juan Maria Farina, MD, Blake Langlais, MS, Bashar Aqel, MD, Ashraf Omar, MD, Jonathan D’Cunha, MD PhD, Pedro Reck dos Santos, MD PhD
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:JHLT Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133425000072
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823864054616162304
author Renita Wilson, BS
J. Asher Jenkins, MD
Juan Maria Farina, MD
Blake Langlais, MS
Bashar Aqel, MD
Ashraf Omar, MD
Jonathan D’Cunha, MD PhD
Pedro Reck dos Santos, MD PhD
author_facet Renita Wilson, BS
J. Asher Jenkins, MD
Juan Maria Farina, MD
Blake Langlais, MS
Bashar Aqel, MD
Ashraf Omar, MD
Jonathan D’Cunha, MD PhD
Pedro Reck dos Santos, MD PhD
author_sort Renita Wilson, BS
collection DOAJ
description Background: Concomitant liver and lung transplant (ConLi-LTx) may be indicated for select pediatric patients with cystic fibrosis (CF). This study aims to analyze pre-transplant predictors and post-transplant outcomes of ConLi-LTx and lung transplant (LTx) only in pediatric patients with cystic fibrosis. Methods: The ISHLT International Thoracic Organ Transplant Registry was queried for patients <18 years old with CF who underwent ConLi-LTx and LTx-only from 1994-June 2018. Data were propensity matched to LTx-only controls and analyzed with Fisher’s exact, Wilcoxon rank sum tests, Kaplan-Meier methods, and Cox proportional hazards where appropriate. Results: We identified 18 ConLi-LTx who were compared to 72 LTx-only cases. No significant differences were identified in patient demographics, resting oxygen requirement prior to transplant, or six-minute walking distance at time of listing. Interestingly, ConLi-LTx patients demonstrated significantly improved overall (p=0.0220) and BOS-free survival (p=0.0167). Conclusions: There were no differences in pre-transplant predictors of simultaneous liver and lung transplantation in pediatric patients with cystic fibrosis compared to those who received LTx-only. The noted survival benefits of ConLi-LTx remains uncertain, as patients who underwent simultaneous transplant are likely well-selected as candidates for such an extensive procedure, and we hypothesize that the liver may play a role in immunologic benefit. Further research is warranted regarding pre-transplant characteristics of pediatric cystic fibrosis patients who may be considered for concomitant liver with lung transplant.
format Article
id doaj-art-084bff0992c248b991b7ba88a6a33bfe
institution Kabale University
issn 2950-1334
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series JHLT Open
spelling doaj-art-084bff0992c248b991b7ba88a6a33bfe2025-02-09T05:02:03ZengElsevierJHLT Open2950-13342025-02-017100212Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry studyRenita Wilson, BS0J. Asher Jenkins, MD1Juan Maria Farina, MD2Blake Langlais, MS3Bashar Aqel, MD4Ashraf Omar, MD5Jonathan D’Cunha, MD PhD6Pedro Reck dos Santos, MD PhD7Mayo Clinic Alix School of Medicine, Phoenix, AZ, United StatesDepartment of Cardiothoracic Surgery, Mayo Clinic Arizona, Phoenix, AZ, United StatesDepartment of Cardiothoracic Surgery, Mayo Clinic Arizona, Phoenix, AZ, United StatesDivision of Clinical Trials and Biostatistics, Mayo Clinic Arizona, Phoenix, AZ, United StatesDivision of Gastroenterology and Hepatology, Mayo Clinic Arizona, Phoenix, AZ, United StatesDivision of Transplant Pulmonology, Mayo Clinic Arizona, Phoenix, AZ, United StatesDepartment of Cardiothoracic Surgery, Mayo Clinic Arizona, Phoenix, AZ, United StatesDepartment of Cardiothoracic Surgery, Mayo Clinic Arizona, Phoenix, AZ, United States; Correspondence to: Department of Cardiothoracic Surgery, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ 85054.Background: Concomitant liver and lung transplant (ConLi-LTx) may be indicated for select pediatric patients with cystic fibrosis (CF). This study aims to analyze pre-transplant predictors and post-transplant outcomes of ConLi-LTx and lung transplant (LTx) only in pediatric patients with cystic fibrosis. Methods: The ISHLT International Thoracic Organ Transplant Registry was queried for patients <18 years old with CF who underwent ConLi-LTx and LTx-only from 1994-June 2018. Data were propensity matched to LTx-only controls and analyzed with Fisher’s exact, Wilcoxon rank sum tests, Kaplan-Meier methods, and Cox proportional hazards where appropriate. Results: We identified 18 ConLi-LTx who were compared to 72 LTx-only cases. No significant differences were identified in patient demographics, resting oxygen requirement prior to transplant, or six-minute walking distance at time of listing. Interestingly, ConLi-LTx patients demonstrated significantly improved overall (p=0.0220) and BOS-free survival (p=0.0167). Conclusions: There were no differences in pre-transplant predictors of simultaneous liver and lung transplantation in pediatric patients with cystic fibrosis compared to those who received LTx-only. The noted survival benefits of ConLi-LTx remains uncertain, as patients who underwent simultaneous transplant are likely well-selected as candidates for such an extensive procedure, and we hypothesize that the liver may play a role in immunologic benefit. Further research is warranted regarding pre-transplant characteristics of pediatric cystic fibrosis patients who may be considered for concomitant liver with lung transplant.http://www.sciencedirect.com/science/article/pii/S2950133425000072Concomitant transplantLung transplantCystic fibrosisPediatric
spellingShingle Renita Wilson, BS
J. Asher Jenkins, MD
Juan Maria Farina, MD
Blake Langlais, MS
Bashar Aqel, MD
Ashraf Omar, MD
Jonathan D’Cunha, MD PhD
Pedro Reck dos Santos, MD PhD
Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study
JHLT Open
Concomitant transplant
Lung transplant
Cystic fibrosis
Pediatric
title Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study
title_full Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study
title_fullStr Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study
title_full_unstemmed Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study
title_short Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study
title_sort outcomes of combined liver lung transplant in pediatric patients with cystic fibrosis an ishlt transplant registry study
topic Concomitant transplant
Lung transplant
Cystic fibrosis
Pediatric
url http://www.sciencedirect.com/science/article/pii/S2950133425000072
work_keys_str_mv AT renitawilsonbs outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy
AT jasherjenkinsmd outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy
AT juanmariafarinamd outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy
AT blakelanglaisms outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy
AT basharaqelmd outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy
AT ashrafomarmd outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy
AT jonathandcunhamdphd outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy
AT pedroreckdossantosmdphd outcomesofcombinedliverlungtransplantinpediatricpatientswithcysticfibrosisanishlttransplantregistrystudy